Dementias Completed Phase 4 Trials for Methylphenidate (DB00422)

Also known as: Dementia / Dementia NOS / Amentia

IndicationStatusPhase
DBCOND0060453 (Dementias)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00254033Apathy Associated With Alzheimer's DiseaseTreatment
NCT00495820Methylphenidate for Apathy in Alzheimer's Dementia: A Controlled StudyTreatment
NCT00914095Study of Methylphenidate to Treat Gait Disorders And Attention Deficit In Parkinson's Disease (PARKGAIT-II)Treatment